Library / Laws / 115th Congress / House Bills / H.R. 6717
H.R. 6717
To amend the Federal Food, Drug, and Cosmetic Act to require that the label of drugs with an increased risk of suicide or depression present such increased risk prominently, and for other purposes.
| Print stage | Date | Size | ⠃ |
|---|---|---|---|
| Introduced in House | 2018-09-06 | 1.4K | ⠃⠗⠋ |